Research
Hormonal
Tirzepatide has potential cardiovascular benefits.
Practitioners should consider the cardiovascular implications when prescribing TZP.
StrongSupportsmedium confidence
New data suggesting improvements in CV outcomes indicate that TZP could set a new standard in the treatment paradigm.
Why this rating
The claim is based on systematic evaluation of data.
Source
Tirzepatide: unveiling a new dawn in dual-targeted diabetes and obesity management
Syed Arman Rabbani et al. · Expert Review of Endocrinology & Metabolism · 2024
reviewCited 5×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →